sodium glycerophosphate Powder for solution for injection 2.16 g - 10 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
ANVISA, China, Malaysia
Manufacturer #18713
This pharmaceutical company, headquartered in a major Chinese city, focuses on research, development, manufacturing, and distribution of high-quality pharmaceuticals globally. Their product portfolio includes prescription medications like Ginkgolide injection, Clindamycin phosphate for injection, Ambroxol hydrochloride injection, and Enoxaparin sodium for injection. Key therapy areas include neurological-psychiatric disorders, cardiocerebrovascular diseases, respiratory illnesses, digestive issues, and antibiotics. The company emphasizes GMP certifications and holds patents for its products. They serve markets in regions like the EU, North America, and beyond.
Manufacturer usually replies in 39 days